USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
WHALEN BIOMEDICAL, INC
Address:
11 MILLER ST
SOMERVILLE, MA 02143-
Phone:
N/A
URL:
N/A
EIN:
42836765
DUNS:
154920409
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,736,259.00 25
SBIR Phase II $5,870,192.00 11

Award List:

THERAPY COSMESIS

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$48,000.00
Agency:
HHS
Principal Investigator:
Robert l whalen , PRINCIPAL INVESTIGATOR
Abstract:
The objective of this proposed program is the development oftwo types of breast prosthesis for cosmetic correction of the effects of minimal breast surgery and/or radiation therapy. the prostheses employ a textured surface to promote tissue attachment and minimize the formation of a tissue capsule,… More

SCAR TISSUE INHIBITION AROUND SOFT TISSUE IMPLANTS

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen , Principal Investigator
Abstract:
N/a

BREAST PROSTHESES FOR SUBRADICAL SURGERY

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$48,262.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
N/a

AN EXTRACORPOREAL PULSATILE ASSIST DEVICE (EPAD)

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen , Principal Investigator
Abstract:
N/a

A RELIABLE, SIMPLE, ELECTRONIC PNEUMATIC PUMP ACTUATOR

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
N/a

AN EXTRACORPOREAL PULSATILE ASSIST DEVICE (EPAD)

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen , Principal Investigator
Abstract:
The objective of this program is the development of an extracorporeal pulsatile assist device (epad), a valveless diastolic augmentation pump with variable stroke volumes up to 80 ml per beat. the epad is designed as a low-cost, disposable device whose initial application will be as a temporary… More

SCAR TISSUE INHIBITION AROUND SOFT TISSUE IMPLANTS

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$476,362.00
Agency:
HHS
Principal Investigator:
Robert L Whalen , Principal Investigator
Abstract:
The objective of this program is the development of an improved mammary prosthesis significantly less prone to the major complication of current devices: the formation of a thickened fibrous tissue capsule around the implant. the basic approach is to alter the surface morphology of the implant from… More

A RELIABLE, SIMPLE, ELECTRONIC PNEUMATIC PUMP ACTUATOR

Award Year / Program / Phase:
1990 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
The goal of the proposed program is the development of a portable, reliable, and simple electromagnetic pump driver for pneumatically actuated blood pump systems. this driver eliminates compressors, pressure regulators, solenoid valves, sliding seals, and any components subject to mechanical wear.… More

BREAST PROSTHESES FOR SUBRADICAL SURGERY

Award Year / Program / Phase:
1990 / SBIR / Phase II
Award Amount:
$460,732.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
The objective of this project is to develop prostheses for subradical surgery and radiation therapy cosmesis. the prostheses employ an integrally textured silicone rubber surface at the tissue interface that promotes tissue attachment to the prosthesis and minimizes tissue capsule formation around… More

MAGNETICALLY OPERATED ARTIFICIAL URETHRAL SPHINCTER

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
N/a

A NEW FINGER-JOINT PROSTHESIS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
N/a

A NEW, SMALL-VESSEL PROSTHESIS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
N/a

A NEW FINGER-JOINT PROSTHESIS

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
A new finger-joint prosthesis is to be designed and tested. it will utilize a titanium hinge. the hinge area is to be encapsulated in an elastomeric jacket whose exterior will have an integrally textured surface designed to promote softtissue ingrowth and attachment. this potentially minimizes… More

A NEW, SMALL-VESSEL PROSTHESIS

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$498,750.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
The objective of this program is to develop a new prosthesis for the replacement of vessels smaller than 6 mm diameter. the prosthesis employs a polyurethane fibril microporous textured surface at the blood interface designed to generate a pseudoneointima (pni) from blood flowing over the surface.… More

MAGNETICALLY OPERATED ARTIFICIAL URETHRAL SPHINCTER

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Robert L Whalen
Abstract:
The objective of this program is the development of a new prosthesis for the treatment of total urinary incontinence. the prosthesis is magnetically operated with an externally worn permanent magnet. the magnet compresses an implanted metal bellows, which pressurizes a urethral cuff to stop theflow… More

Novel Medicated Dental Floss for Dental Prophylaxis

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$47,129.00
Agency:
HHS
Principal Investigator:
Mark A. Bowen
Abstract:
The purpose is the development of an improved dental floss incorporating a medicated lubricant for the prevention of gingivitis and other periodontal diseases. Gingivitis is largely caused by bacterial activity. Efforts to control intraoral flora by the use of antimicrobial agents, particularly… More

Mechanical Heart Valves with Reduced Thromboembolic Risk

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$74,473.00
Agency:
HHS
Principal Investigator:
Robert Whalen
Abstract:
Our objective is to develop of a mechanical prosthetic heart valve with reduced thromboembolicrisk compared to valves currently available. Mechanical valves now are employed only with warfarinanticoagulation, a significant contributor to the morbidity and mortality associated with their use.… More

Tissue Adhesives for Battlefield Hemorrhage Control

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$68,831.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Robert L. Whalen, Phd
Abstract:
The objective of this program is the development of a fibrin tissue adhesive which will be usable under battlefield conditions. The new adhesive will be a blood activated, single agent system which is applied directly to the site of bleeding. It consists chiefly of a mixture of fibrin monomer and… More

Delivery of Vaccines by Biodegradable Polymeric Microcapsules with Bioadherence Properties

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$69,651.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Robert L. Whalen, Ph.d.
Abstract:
The objective of this program is to demonstrate the feasiility of using iodegradable polymeric microspheres for the encapsulation of vaccines which would produce effective protection for a minimum duration of one year with a single adminstration. Biodegradable microspheres made from poly (D-lactide… More

Pump/Oxygenator for Pediatric Cardiopulmonary Support

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$75,000.00
Agency:
HHS
Principal Investigator:
Robert Whalen
Abstract:
The objective of this program is the development of an integrated pump/oxygenator for pediatric carsupport. The device employs an axial flow pump to produce secondary flows in a tubular membrane oxygworking pressure. The outflow from the oxygenator is then returned to the patient's circulation by… More

Infection Inhibiting Urinary Catheter Material

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$72,250.00
Agency:
HHS
Principal Investigator:
Mark Bowen
Abstract:
We will develop a new urinary catheter material incorporating an antimicrobial agent that will be rbacteriostatic levels for up to 30 days in a sustained, controlled manner. This will significantly rorganisms associated with Urinary Tract Infection (UTI), the most common nosocomial infection… More

Tissue Adhesives fro Battlefield Hemorrhage Control

Award Year / Program / Phase:
1995 / SBIR / Phase II
Award Amount:
$557,657.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Abstract:
N/a

NOVEL ARTERIOVENOUS GRAFT FISTULA FOR HEMODIALYSIS

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$98,358.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

TRANSCUTANEOUS POWER SYSTEM FOR ROTARY BLOOD PUMPS

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$98,360.00
Agency:
HHS
Principal Investigator:
Sherman, Craig W
Abstract:
N/a

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase II
Award Amount:
$750,027.00
Agency:
HHS
Principal Investigator:
Sherman Craig W
Abstract:
N/a

CONDUCTANCE TELEMETRY SYSTEM FOR IMPLANTED BLOOD PUMPS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$91,354.00
Agency:
HHS
Principal Investigator:
Craig W. Sherman
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,045.00
Agency:
HHS
Principal Investigator:
Robert L. Whalen
Abstract:
N/a

A conductance telemetry system for implant blood pumps

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Craig W. Sherman
Abstract:
DESCRIPTION (provided by applicant): An ideal permanent ventricular assist system (VAS) or total artificial heart (TAH) will not include tubes or wires passing through the skin. This proposal describes development of a telemetry system capable of providing the… More

A conductance telemetry system for implant blood pumps

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$376,664.00
Agency:
HHS
Principal Investigator:
Craig W. Sherman
Abstract:
DESCRIPTION (provided by applicant): An ideal permanent ventricular assist system (VAS) or total artificial heart (TAH) will not include tubes or wires passing through the skin. This proposal describes development of a telemetry system capable of providing the… More

A drug releasing urinary catheter

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Catheter-associated urinary tract infection (UTIc) is the most common nosocomial infection acquired in hospitals and nursing homes. The goal of this Phase II program is to continue the development and evaluation of a new, drug releasing urinary catheter… More

A drug releasing urinary catheter

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Catheter-associated urinary tract infection (UTIc) is the most common nosocomial infection acquired in hospitals and nursing homes. The goal of this Phase II program is to continue the development and evaluation of a new, drug releasing urinary catheter… More

Vehicular power adapter for implanted blood pumps

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,525.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With the approval by the Food and Drug Administration in 2003 of electrically powered ventricular assist systems as destination therapy (i.e., as an alternative to cardiac transplantation), the number of patients with implanted electrically powered devices in… More

An all titanium transcutaneous access device (TAD) for peritoneal dialysis

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$102,256.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Chronic transcutaneous access is needed for peritoneal dialysis (PD) and new emerging medical therapies. Since a transcutaneous device breeches the skin, the normal barrier to bacterial entry, infection is a significant problem over long periods. The objective… More

A system to monitor the inlet pressure of rotary blood pumps

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$85,747.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Axial flow rotary blood pumps have been successfully introduced clinically to provide prolonged mechanical circulatory support, but these devices do not provide load-responsive mechanisms for adjusting pump performance to match venous return and changes in… More

A new negative pressure ventilator

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$103,588.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Long-term respiratory support using endotracheal intubation and positive pressure ventilation is associated with very high rates of infection, and ventilator-associated pneumonia (VAP) is among the leading and more seri ous forms of nosocomial infection in… More

A point-of-care device for generating nitric oxide for inhalation

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$152,430.00
Agency:
HHS
Principal Investigator:
Robert L. Whalen – 617-868-4433
Abstract:
DESCRIPTION (provided by applicant): Nitric oxide (NO) gas was considered to be a highly toxic pollutant as recently as the 1980s. It is now recognized to be an important messenger molecule in mammalian physiology. Inhaled NO is currently used to treat approximately 25,000 patients per year in this… More